Cargando…
Hairy Cell Leukemia Treatment: Where We Are Now?
Hairy cell leukemia (HCL) is a very rare type of leukemia, in which abnormal B lymphocytes, present in the bone marrow, spleen, and peripheral blood stream, get worse slowly or do not get worse at all. HCL is the disease where patients have pancytopenia with splenomegalia over 90% percent, palpable...
Autores principales: | Krstevska, Svetlana, Genadieva-Stavric, Sonja, Sotirova, Tatjana, Spasovski, Dejan, Balkanov, Trajan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AVICENA, d.o.o., Sarajevo
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3633398/ https://www.ncbi.nlm.nih.gov/pubmed/23678301 http://dx.doi.org/10.5455/msm.2011.23.227-229 |
Ejemplares similares
-
Influence of Prognostic Factors on OverallSurvival in Myelodysplastic Syndromes
por: Sotirova, Tatjana, et al.
Publicado: (2014) -
Tretatment Approach of Nontransplant Patients with Multiple Myeloma
por: Krstevska, Svetlana B., et al.
Publicado: (2014) -
Osteonecrosis of the Jaw After Bisphosphonates Treatment in Patients with Multiple Myeloma
por: Krstevska, Svetlana, et al.
Publicado: (2015) -
Adverse Effects of Thalidomide Administration, in Patients with Myeloma Multiplex?
por: Svetlana Balkanov, Krstevska, et al.
Publicado: (2014) -
Determination of the Diagnostic Values of Asymmetric Dimethylarginine as an Indicator for Evaluation of the Endothelial Dysfunction in Patients with Rheumatoid Arthritis
por: Spasovski, Dejan, et al.
Publicado: (2013)